Evaluating insomnia treatment to lower heart disease risk in PTSD patients
An evaluation of insomnia treatment to reduce cardiovascular risk in patients with posttraumatic stress disorder
This study is looking at how helping people with PTSD sleep better can also lower their chances of heart problems, using a special therapy called CBT-I to improve their sleep and checking their heart health along the way.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10890044 on NIH RePORTER |
What this research studies
This research investigates how treating insomnia in patients with posttraumatic stress disorder (PTSD) can reduce their risk of cardiovascular disease. The study will utilize cognitive behavioral therapy for insomnia (CBT-I) to improve sleep quality and assess its effects on various cardiovascular health markers. Patients will undergo tests to measure blood pressure, vascular function, and sympathetic nervous system activity, which are crucial for understanding heart health. The goal is to uncover the relationship between improved sleep and reduced cardiovascular risks in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have been diagnosed with PTSD and experience insomnia.
Not a fit: Patients without PTSD or those who do not experience insomnia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments that significantly lower cardiovascular risks for patients suffering from PTSD.
How similar studies have performed: Previous research has shown promising results in using cognitive behavioral therapy to improve sleep and health outcomes, suggesting potential success for this approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Beckham, Jean C. — Duke University
- Study coordinator: Beckham, Jean C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.